Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Deschloroetizolam"'
Publikováno v:
Arhiv za Higijenu Rada i Toksikologiju, Vol 74, Iss 4, Pp 224-231 (2023)
This review article takes a closer look at a new class of psychoactive substances called designer benzodiazepines (DBZs) and the challenges of their detection. These are adinazolam, clonazolam, deschloroetizolam, diclazepam, etizolam, flualprazolam,
Externí odkaz:
https://doaj.org/article/c2dd4da89e61499b81a3b59266f88992
Autor:
Amber N. Edinoff, Catherine A. Nix, Amira S. Odisho, Caroline P. Babin, Alyssa G. Derouen, Salim C. Lutfallah, Elyse M. Cornett, Kevin S. Murnane, Adam M. Kaye, Alan D. Kaye
Publikováno v:
Neurology International, Vol 14, Iss 3, Pp 648-663 (2022)
As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines. Flubromazolam(8-bromo-6-(2-fluorophenyl)-1-methyl-4H
Externí odkaz:
https://doaj.org/article/3710db9aecf84b2698584a0b52b118ea
Publikováno v:
Clinical Mass Spectrometry. 10:25-32
Hundreds of new psychoactive substances (NPS) covering most drugs-of-abuse classes have been introduced to the recreational drug market in recent years. One class of NPS drugs that has become more common recently is “designer” benzodiazepines. Du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eeb2172205c2087199e9ebdb9952b04
https://doi.org/10.1016/j.clinms.2018.08.004
https://doi.org/10.1016/j.clinms.2018.08.004
Autor:
Francesco Paolo Busardò, Pietro Brunetti, Adriano Tagliabracci, Raffaele Giorgetti, Marilyn A. Huestis
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 560, p 560 (2021)
Pharmaceuticals, Vol 14, Iss 560, p 560 (2021)
The rising use of designer benzodiazepines (DBZD) is a cat-and-mouse game between organized crime and law enforcement. Non-prohibited benzodiazepines are introduced onto the global drug market and scheduled as rapidly as possible by international aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92324ebc63606e1c89578ce19241e24c
https://pubmed.ncbi.nlm.nih.gov/34208284
https://pubmed.ncbi.nlm.nih.gov/34208284
Publikováno v:
Drug Testing and Analysis. 10:1258-1269
The misuse of benzodiazepines as new psychoactive substances is an increasing problem around the world. Basic physicochemical and pharmacokinetic data is required on these substances to interpret and predict their effects upon humans. Experimental lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb828279e9d28cf82ec804a0b47e0627
https://doi.org/10.1002/dta.2387
https://doi.org/10.1002/dta.2387
Publikováno v:
Talanta. 176:69-76
A novel non-aqueous capillary electrophoresis - tandem mass spectrometry method for the simultaneous separation, identification and quantification of nine designer benzodiazepines (bentazepam, etizolam, deschloroetizolam, diclazepam, flubromazepam, f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc06c8c8116c287d554bc8952ce00b5
https://doi.org/10.1016/j.talanta.2017.08.010
https://doi.org/10.1016/j.talanta.2017.08.010
Publikováno v:
Journal of analytical toxicology. 43(9)
The misuse of designer benzodiazepines, as an alternative to prescription benzodiazepines and for drug-facilitated sexual assaults, has emerged as a growing threat, due in part to the ease of purchasing these drugs on the internet at low prices. Caus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b454e84cfff896e0e2f4b5cf9da9ad9d
https://pubmed.ncbi.nlm.nih.gov/31436813
https://pubmed.ncbi.nlm.nih.gov/31436813
Publikováno v:
Drug Testing and Analysis. 9:640-645
The emerging new psychoactive substances made available for recreational drug use have recently started to include designer benzodiazepines. As a consequence, the routine immunoassay drug testing for benzodiazepines may become less effective, due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbb9fc7253a733db842fa8a056df3d5b
https://doi.org/10.1002/dta.2003
https://doi.org/10.1002/dta.2003
Autor:
Markus R. Meyer, Hans H. Maurer, Lea Wagmann, Madeleine Pettersson Bergstrand, Lilian H.J. Richter
Publikováno v:
Drug testing and analysis. 11(1)
Multiple new psychoactive substances (NPS) are released into the recreational drug market each year. One NPS drug class that has become more common in recent years is that of the benzodiazepines (designer benzodiazepines, DBZ). Several metabolism stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0606026629407c7721179d395725f1
https://pubmed.ncbi.nlm.nih.gov/29996009
https://pubmed.ncbi.nlm.nih.gov/29996009
Publikováno v:
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, 2018, 40 (6), pp.759-761. ⟨10.1097/FTD.0000000000000557⟩
Therapeutic Drug Monitoring, 2018, 40 (6), pp.759-761. ⟨10.1097/FTD.0000000000000557⟩
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac5eaa244b641296db0b1ced3d3e27b
https://hal.science/hal-03622297
https://hal.science/hal-03622297
